Kensil C - Search Results

1

A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.

Meraldi V, Romero JF, Kensil C, Corradin G. Meraldi V, et al. Among authors: kensil c. Vaccine. 2005 Apr 15;23(21):2801-12. doi: 10.1016/j.vaccine.2004.10.044. Vaccine. 2005. PMID: 15780728

2

QS-21 structure/function studies: effect of acylation on adjuvant activity.

Liu G, Anderson C, Scaltreto H, Barbon J, Kensil CR. Liu G, et al. Among authors: kensil cr. Vaccine. 2002 Jun 21;20(21-22):2808-15. doi: 10.1016/s0264-410x(02)00209-8. Vaccine. 2002. PMID: 12034108

3

Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.

Newman MJ, Wu JY, Gardner BH, Anderson CA, Kensil CR, Recchia J, Coughlin RT, Powell MF. Newman MJ, et al. Among authors: kensil cr. Vaccine. 1997 Jun;15(9):1001-7. doi: 10.1016/s0264-410x(96)00293-9. Vaccine. 1997. PMID: 9261947

4

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.

Soltysik S, Wu JY, Recchia J, Wheeler DA, Newman MJ, Coughlin RT, Kensil CR. Soltysik S, et al. Among authors: kensil cr. Vaccine. 1995;13(15):1403-10. doi: 10.1016/0264-410x(95)00077-e. Vaccine. 1995. PMID: 8578817

5

Epidermal powder immunization of mice and monkeys with an influenza vaccine.

Chen D, Endres R, Maa YF, Kensil CR, Whitaker-Dowling P, Trichel A, Youngner JS, Payne LG. Chen D, et al. Among authors: kensil cr. Vaccine. 2003 Jun 20;21(21-22):2830-6. doi: 10.1016/s0264-410x(03)00175-0. Vaccine. 2003. PMID: 12798624

6

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma.

Livingston PO, Adluri S, Helling F, Yao TJ, Kensil CR, Newman MJ, Marciani D. Livingston PO, et al. Among authors: kensil cr. Vaccine. 1994 Nov;12(14):1275-80. doi: 10.1016/s0264-410x(94)80052-2. Vaccine. 1994. PMID: 7856291 Clinical Trial.

7

Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats.

Marciani DJ, Kensil CR, Beltz GA, Hung CH, Cronier J, Aubert A. Marciani DJ, et al. Among authors: kensil cr. Vaccine. 1991 Feb;9(2):89-96. doi: 10.1016/0264-410x(91)90262-5. Vaccine. 1991. PMID: 1647576

8

Author response to letter to the editor by Marciani et al.

Liu G, Kensil CR. Liu G, et al. Among authors: kensil cr. Vaccine. 2003 Mar 28;21(13-14):1303. doi: 10.1016/s0264-410x(02)00695-3. Vaccine. 2003. PMID: 12615423 No abstract available.

9

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.

Ma J, Bulger PA, Davis DR, Perilli-Palmer B, Bedore DA, Kensil CR, Young EM, Hung CH, Seals JR, Pavia CS, et al. Ma J, et al. Among authors: kensil cr. Vaccine. 1994 Aug;12(10):925-32. doi: 10.1016/0264-410x(94)90036-1. Vaccine. 1994. PMID: 7975834

10

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21.

Waite DC, Jacobson EW, Ennis FA, Edelman R, White B, Kammer R, Anderson C, Kensil CR. Waite DC, et al. Among authors: kensil cr. Vaccine. 2001 Jul 16;19(28-29):3957-67. doi: 10.1016/s0264-410x(01)00142-6. Vaccine. 2001. PMID: 11427271 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters